Injectable
Triptorelin pamoate
eq. 22.5 mg base per vial · Powder for IM injection · Advanced prostate cancer (palliative)
Product data
- Strength
- eq. 22.5 mg base per vial
- Dosage form
- Powder for IM injection
- Dosage-form group
- Injectable
- Therapeutic area
- Advanced prostate cancer (palliative)
- Status
- Under development
- Portfolio
- Injectable
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23